Vaccine

Details for Australian Patent Application No. 2008239670 (hide)

Owner Dana-Farber Cancer Institute Duke University

Inventors Ma, Ben-Jiang; Haynes, Barton F.; Liao, Hua-Xin; Sodroski, Joseph

Agent Cullens

Pub. Number AU-A-2008239670

PCT Pub. Number WO2008/127596

Priority 60/907,719 13.04.07 US

Filing date 10 April 2008

Wipo publication date 23 October 2008

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

3 December 2009 PCT application entered the National Phase

  PCT publication WO2008/127596 Priority application(s): WO2008/127596

3 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008239680-Process for making topotecan

2008239668-Combination therapies comprising quinoxaline inhibitors of PI3K-alpha for use in the treatment of cancer